Spero Therapeutics grants new employee 217,000 RSUs and 434,000 stock options
SPRO•Spero Therapeutics granted a new employee 217,000 restricted stock units and 434,000 stock options on Nov. 2, 2026, under its amended 2019 Inducement Equity Incentive Plan.




